Denosumab for Prevention of Acute Onset Immobilization‐Induced Alterations of Bone Turnover: A Randomized Controlled Trial

Metabolic bone disease is a devastating condition in critically ill patients admitted to an intensive care unit (ICU). We investigated the effects of early administration of the antiresorptive drug denosumab on bone metabolism in previously healthy patients. Fourteen patients with severe intracerebr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wadiura, Lisa Irina, Butylina, Maria, Reinprecht, Andrea, Aretin, Marie‐Bernadette, Mischkulnig, Mario, Gleiss, Andreas, Pietschmann, Peter, Kerschan‐Schindl, Katharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086960/
https://www.ncbi.nlm.nih.gov/pubmed/36056473
http://dx.doi.org/10.1002/jbmr.4694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086960/
https://www.ncbi.nlm.nih.gov/pubmed/36056473
http://dx.doi.org/10.1002/jbmr.4694

Ejemplares similares